PERFORMANCE OF NON-INVASIVE FIBROSIS TESTS ACROSS BMI CATEGORIES IN PATIENTS WITH MASLD

N. Al Maimouni; S.Salhani; N. El Khamlichi; I. El Fadli; K.Nadiri A. Akjay; H.Ouaya; H. Meyiz; I. Mellouki

doi:10.21474/IJAR01/23379

20 Apr 2026 Vol. 14 (04) pp. 1454-1462 DOI: 10.21474/IJAR01/23379

PERFORMANCE OF NON-INVASIVE FIBROSIS TESTS ACROSS BMI CATEGORIES IN PATIENTS WITH MASLD

N. Al Maimouni, S.Salhani, N. El Khamlichi, I. El Fadli, K.Nadiri A. Akjay, H.Ouaya, H. Meyiz and I. Mellouki

Service d Hepato-Gastroenterologie, Centre Hospitalier Universitaire de Tanger, Maroc.

2 Downloads 48 Views

Download Full Paper (PDF)

Abstract

Background and Aims: Non-invasive tests (NITs) are essential for screening advanced fibrosis in metabolic dysfunction associated steatotic liver disease (MASLD). However, their clinical reliability across different body mass index (BMI) categories remains debated. The objective of this prospective study is to evaluate and compare the diagnostic performance of Vibration-Controlled Transient Elastography (FibroScan) and serum scores (FIB-4 and NFS) across different Body Mass Index (BMI) categories in patients with MASLD.

Keywords

How to Cite This Article

N. Al Maimouni (2026); PERFORMANCE OF NON-INVASIVE FIBROSIS TESTS ACROSS BMI CATEGORIES IN PATIENTS WITH MASLD, International Journal of Advanced Research (IJAR), 14 (04), 1454-1462, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/23379